NCT02060565 Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
| NCT ID | NCT02060565 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association HGE CHU Bordeaux Sud |
| Condition | Chronic Liver Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2014-02 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2014-02 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.
Eligibility Criteria
Inclusion Criteria: * chronic hepatitis C * chronic hepatitis B * alcohol liver disease * non alcoholic liver disease Exclusion Criteria: * ascitis
Contact & Investigator
Juliette Foucher, MD
STUDY CHAIR
Association HGE CHU Bordeaux Sud
Frequently Asked Questions
Who can join the NCT02060565 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Liver Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02060565 currently recruiting?
Yes, NCT02060565 is actively recruiting participants. Contact the research team at victor.deledinghen@chu-bordeaux.fr for enrollment information.
Where is the NCT02060565 trial being conducted?
This trial is being conducted at Pessac, France.
Who is sponsoring the NCT02060565 clinical trial?
NCT02060565 is sponsored by Association HGE CHU Bordeaux Sud. The principal investigator is Juliette Foucher, MD at Association HGE CHU Bordeaux Sud. The trial plans to enroll 10,000 participants.